ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,346.99
      -0.11%
      US Tech 100
      18,488.00
      -0.25%
      Dow Jones
      38,798.99
      -0.22%
      Brent Oil
      79.395
      0.00%
      Bitcoin
      69,283.44
      -0.03%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. ETFs
      4. USA
      5. AMEX
      6. Emles at Home ETF (LIV)

      7. Emles at Home ETF (LIV) News

      LIV

      Emles at Home ETF (LIV)

      Emles at Home ETF
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:LIV
      DateTimeSourceHeadlineSymbolCompany
      09/16/20225:00PMPR Newswire (US)Emles Advisors Announces Closure of Six FundsAMEX:LIVEmles at Home ETF
      12/13/200710:15AMEdgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
      11/27/20079:17AMEdgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
      11/19/200712:52PMEdgar (US Regulatory)Samaritan Pharmaceuticals Inc - Quarterly Report (10-Q)AMEX:LIVEmles at Home ETF
      11/15/20072:16PMEdgar (US Regulatory)Samaritan Pharmaceuticals Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)AMEX:LIVEmles at Home ETF
      11/13/20076:06AMEdgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other)AMEX:LIVEmles at Home ETF
      11/08/200710:06AMEdgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filingAMEX:LIVEmles at Home ETF
      10/03/20079:54AMEdgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
      10/03/20079:54AMEdgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
      10/01/200710:00AMEdgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other) (8-K)AMEX:LIVEmles at Home ETF
      09/28/200710:00AMEdgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other) (8-K)AMEX:LIVEmles at Home ETF
      09/21/20074:43PMEdgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other) (8-K)AMEX:LIVEmles at Home ETF
      09/20/200710:00AMEdgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other) (8-K)AMEX:LIVEmles at Home ETF
      09/18/20079:10AMEdgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
      06/15/200610:09AMBusiness WireSamaritan to Initiate Phase III Clinical Trial in Europe to Accelerate Development Timeline of Its HIV Oral Entry Inhibitor SP0AMEX:LIVEmles at Home ETF
      05/30/20068:59AMBusiness WireSamaritan Reports Positive Preliminary Results with ''Oral'' HIV Entry Inhibitor in Phase II 10-Day HIV Monotherapy TrialAMEX:LIVEmles at Home ETF
      05/23/20069:22AMBusiness WireSamaritan Files Provisional Patent to Support Promising New Type of Anti-cholesterol Drug SP-1000 and Cover Additional Claims;AMEX:LIVEmles at Home ETF
      05/02/20069:15AMBusiness WireSamaritan Starts Enrolling for Its PII Stage 2 (28 Day Monotherapy) Study of ''Oral'' Entry Inhibitor SP-01AAMEX:LIVEmles at Home ETF
      04/25/20068:00AMBusiness WireSIS Foundation Driven to Drive Bio Future Bus So Kids Can Speed up Science Innovation; Only 17% of US Students Graduate with ScAMEX:LIVEmles at Home ETF
      04/13/20061:13PMBusiness WireBio 2006 Analysts Predict Small-Cap Biotechs to Outperform Large-Caps This YearAMEX:LIVEmles at Home ETF
      04/06/20068:30AMBusiness WireLIV to Host Annual Shareholders MeetingAMEX:LIVEmles at Home ETF
      04/04/20069:15AMBusiness WireSamaritan's Marketing Authorization Application For Amphocil Approved in GreeceAMEX:LIVEmles at Home ETF
      03/30/20069:15AMBusiness WireSamaritan to Present Its Drugs and Diagnostics for Partnering at BIO 2006 Annual International ConferenceAMEX:LIVEmles at Home ETF
      03/28/20069:27AMBusiness WireNew Preclinical Data Shows Samaritan's Cardiovascular Drug Reduces Cholesterol; Cardiovascular Disease is a $15B Market WorldwiAMEX:LIVEmles at Home ETF
      03/23/20069:30AMBusiness WireSamaritan is the Little Biotech That Could Be Remembered for Alzheimer'sAMEX:LIVEmles at Home ETF
      03/21/200611:01PMBusiness WireCORRECTING and REPLACING Samaritan's Adult Stem Cell Drug Displays Money-Making SignsAMEX:LIVEmles at Home ETF
      03/21/200610:29AMBusiness WireSamaritan's Adult Stem Cell Drug Displays Money-Making SignsAMEX:LIVEmles at Home ETF
      03/09/20068:00AMBusiness WireUPDATE: Samaritan Kicks Off Follow-On HIV StudyAMEX:LIVEmles at Home ETF
      03/01/20068:00AMBusiness WireDistinguished Cancer Drug Developer Joins Samaritan Scientific Advisory BoardAMEX:LIVEmles at Home ETF
      02/28/20068:00AMBusiness WireSamaritan's Alzheimer's Drug Registered as CAPROSPINOL; SP-233 (Caprospinol) is Believed to Exhibit Neuroprotective PropertiesAMEX:LIVEmles at Home ETF
       Showing the most relevant articles for your search:AMEX:LIV